Local pharmaceutical entrepreneur Jay Bhaumik is entering his next era with BMK Pharma. The forthcoming 50,000-square-foot ...

From endless applications to small victories, readers reveal what job hunting in Greater Boston really feels like right now.

OKLAHOMA CITY — The City Council on Tuesday approved a pay-for-performance economic development incentive not to exceed $600,000 for a biopharmaceutical company’s expansion that promises to create ...

WASHINGTON, DC — The construction industry lost 7,000 jobs in August, according to data released by the US Bureau of Labor Statistics. On a year-over-year basis, industry employment has grown by ...

European pharmaceutical stocks traded sharply higher after President Trump unveiled plans to launch a drug-buying website for consumers and a pricing deal with Pfizer, in a move that analysts say ...

UC Berkeley professor Hany Farid says computer science students are struggling to find jobs. Farid said Berkeley grads used to have "the run of the place. That is not happening today." The advice ...

President Donald Trump announced Thursday that brand-name or patented pharmaceutical products will be subject to a 100% tariff starting October 1 – unless the drugmaker is building a manufacturing ...

AstraZeneca AZN0.29%increase; green up pointing triangle said it will offer its asthma and diabetes drugs at an up to 70% discount in the U.S. ahead of a Trump administration deadline for ...

Robert Bosch GmbH will cut about 13,000 additional jobs at its auto-parts business as rising competition and a sluggish European car market push the manufacturer into deeper restructuring. The ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Robert Bosch GmbH will cut about 13,000 additional jobs at ...

The pharmaceutical industry is a major player in the overall life science sector, responsible for developing and manufacturing the majority of prescription drugs. Companies in this space are ...

Global drugmakers including Merck & Co., Eli Lilly & Co. and AstraZeneca Plc are pausing or canceling investments in the UK while throwing barbs at the lack of competitiveness of its business ...